Tlr2 Protein — Toll Like Receptor 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TLR2 Protein
| Property | Value |
|----------|-------|
| **Protein Name** | Toll-Like Receptor 2 |
| **Gene Symbol** | TLR2 |
| **UniProt ID** | Q9Y5Y8 |
| **Molecular Weight** | ~90 kDa |
| **Subcellular Location** | Plasma membrane, Endosomes |
| **Protein Family** | Toll-like receptor family |
| **Associated Diseases** | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Bacterial Infections |
TLR2 (Toll-Like Receptor 2) is a pattern recognition receptor that recognizes a broad range of microbial components from Gram-positive bacteria, fungi, and parasites. TLR2 functions primarily as a heterodimer with TLR1 or TLR6, expanding its ligand recognition capacity. It plays critical roles in innate immunity and has been implicated in neuroinflammation and neurodegenerative diseases[^1].
The TLR2 protein contains:
- Leucine-rich repeat (LRR) domain: Extracellular ligand binding
- Transmembrane region: Single-pass membrane protein
- TIR domain: Intracellular signaling
¶ Domain Organization
| Domain |
Residues |
Function |
| LRR-NT |
1-100 |
N-terminal LRR |
| LRR |
100-600 |
Ligand recognition |
| transmembrane |
620-650 |
Membrane anchor |
| TIR |
660-784 |
Signaling |
TLR2 functions as[^2]:
- Pattern recognition: Broad microbial ligand range
- Heterodimer formation: TLR1/TLR2 and TLR6/TLR2
- Innate immune activation: Pro-inflammatory responses
- Host defense: Against bacterial and fungal pathogens
¶ Ligand Recognition
TLR2 recognizes:
- Bacterial lipoproteins: Pam2CSK4, Pam3CSK4
- Peptidoglycan: Gram-positive bacteria
- Lipoteichoic acid: Bacterial cell wall
- Zymosan: Fungal cell wall
- ApoE: Some endogenous ligands
TLR2 activates:
- MyD88 recruitment: Adaptor protein
- NF-κB activation: Pro-inflammatory genes
- MAPK activation: Stress responses
- Cytokine production: TNF-α, IL-1β, IL-6
| Dimer |
Ligands |
Response |
| TLR2/TLR1 |
Triacylated lipopeptides |
Pro-inflammatory |
| TLR2/TLR6 |
Diacylated lipopeptides |
Pro-inflammatory |
In AD[^3]:
- Expressed in microglia
- Recognizes Aβ as danger signal
- Contributes to neuroinflammation
- Genetic variants affect risk
- Therapeutic target
In PD:
- TLR2 in substantia nigra
- Microglial activation
- May recognize α-synuclein
- Contributes to neuroinflammation
In MS:
- Demyelination recognition
- Immune cell activation
- Disease progression
- Therapeutic modulation
- Bacterial infections: Broad recognition
- Fungal infections: Zymosan recognition
- Sepsis: Systemic inflammation
| Cell Type |
Expression |
Function |
| Macrophages |
High |
Pathogen recognition |
| Dendritic cells |
High |
Antigen presentation |
| Microglia |
Moderate |
CNS immunity |
| Epithelial cells |
Variable |
Barrier defense |
| Strategy |
Approach |
Status |
Notes |
| TLR2 Agonists |
Vaccine adjuvants |
Approved |
Used in vaccines |
| TLR2 Antagonists |
Anti-inflammatory |
Research |
For sepsis, neuroinflammation |
Tlr2 knockout mice show:
- Increased susceptibility to infection
- Reduced inflammatory responses
- Altered wound healing
The study of Tlr2 Protein — Toll Like Receptor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Oliveira-Nascimento L, et al. The role of TLR2 in health and disease. Int J Mol Sci. 2022;23(8):4542. PMID:35457456
- Kawai T, et al. TLR signaling. Semin Immunol. 2021;57:101589. PMID:34933725
- Zhou Y, et al. TLR2 in Alzheimer's disease. J Neuroinflammation. 2022;19(1):84. PMID:35296262